Abstracts

GLOBAL AND REGIONAL ESTIMATES OF THE CONTRIBUTION OF HSV-2 TO INCIDENT HIV INFECTIONS

Evidence of biological interactions between herpes simplex virus type 2 (HSV-2) and HIV suggests that HSV-2 plays an important role in HIV epidemics. We improved previous estimates of the contribution of HSV-2 to incident HIV infections using a dynamic-transmission model accounting for direct/indirect transmissions (using population-attributable fractions (tPAFs)). We developed a mathematical model of HSV-2/HIV…

THE IMPACT OF VIOLENCE ON PrEP ADHERENCE AMONG US CISGENDER WOMEN AT RISK FOR HIV

Violence is prevalent against women at-risk for HIV; survivors are at increased behavioral risk for HIV, while survivorship is linked to higher HIV susceptibility, via dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis and female genital tract (FGT) microenvironment after physical or psychological trauma. Pre-exposure prophylaxis (PrEP) for HIV can mitigate this risk, but adherence remains challenging.…

PREDICTORS OF PrEP ADHERENCE AND RETENTION IN US CISGENDER WOMEN AT RISK FOR HIV

HIV pre-exposure prophylaxis (PrEP) effectiveness depends on adherence, which requires retention in PrEP care. We examined factors associated with PrEP adherence and retention among at-risk cisgender women prescribed oral PrEP. Adherence Enhancement Guided by Individualized Texting and Drug Levels (AEGiS) was a 48-week single-arm open-label demonstration study of daily oral tenofovir disoproxil fumarate/emtricitabine in cisgender…

PHARMACOKINETICS OF TAF/EVG RECTAL INSERTS IN MACAQUES AND IMPACT OF RECTAL WASH

On-demand topical products for HIV prevention may have several advantages, including limited cost and systemic toxicity. CONRAD has developed inserts containing tenofovir alafenamide fumarate (TAF) and elvitegravir (EVG) for on-demand vaginal or rectal pericoital use. We recently showed that TAF/EVG inserts provided high protection as PrEP or PEP in pigtail macaques exposed vaginally to simian…

ACCEPTABILITY AND CHOICE FOR 3 PLACEBO PRODUCTS USED WITH RECEPTIVE ANAL SEX

End-user perspectives are vital to the design of new biomedical HIV prevention products. Behaviorally congruent alternatives to condoms and daily oral Pre-Exposure Prophylaxis (PrEP) remain crucial. MTN-035 evaluated the acceptability of and preference for three placebo, non-gel delivery vehicles (insert, enema, suppository) that could be used to deliver PrEP prior to receptive anal sex (RAS).…